Interleukin-6 and Thrombopoietin Concentrations in Dogs with Carcinoma with and Without Thrombocytosis

Overview

Journal J Vet Intern Med

Specialties General Medicine
Veterinary Medicine

Date 2021 Dec 9

PMID 34881459

Citations 3

Authors

Adrienne Cheney

Andrew D Woolcock

Abhijit Mukhopadhyay

Deborah Knapp

George E Moore

Affiliations

Soon will be listed here.

Abstract

Background: Carcinoma-associated thrombocytosis involves tumor production of mediators such as interleukin-6 (IL-6) and thrombopoietin (TPO) that increase thrombopoiesis and may play a role in tumor evasion and metastasis. Carcinoma-associated thrombocytosis is described in people, but has not been described in dogs.

Hypothesis/objectives: Evaluate the concentrations of IL-6 and TPO in dogs diagnosed with carcinoma with or without thrombocytosis. We hypothesized that IL-6 and TPO concentrations would be higher in dogs with carcinoma compared to healthy dogs, and that IL-6 and TPO concentrations would be higher in dogs with carcinoma and thrombocytosis when compared to dogs with carcinoma and normal platelet counts.

Animals: One-hundred sixteen dogs: 63 with carcinoma and 53 healthy control dogs.

Methods: Complete blood count was performed in all dogs, and they were stratified for sub-group analysis based on the presence or absence of thrombocytosis (platelet count > 500 103/µL). Serum TPO and IL-6 concentrations were measured by ELISA. Results of selected numeric variables were compared using Wilcoxon rank sum tests for pairwise comparisons. A value of P < .05 was considered significant.

Results: Twelve of the dogs with carcinoma (12/63, 19.0%) and none of the healthy control dogs (0%) had thrombocytosis. Thrombopoietin concentrations (median [range]) were significantly higher in dogs with carcinoma when compared to controls (87.42 pg/mL [0 to >600] vs 15.99 pg/mL [0 to >600], P < .001). Interleukin-6 concentrations (median [range]) were not different between dogs with carcinoma and healthy control dogs (9.70 pg/mL [0-181.53] vs 3.03 pg/mL [0-280.77], P = .15). In dogs with carcinoma, the TPO and IL-6 concentrations were not different between dogs with thrombocytosis and dogs with normal platelet count.

Conclusions And Clinical Importance: Thrombopoietin concentrations were significantly higher in dogs with carcinoma, regardless of platelet count. Thrombopoietin is likely to be 1 of multiple factors that can impact platelet number, production, and consumption in dogs with carcinoma.

Citing Articles

Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia.

Brooks M, Brooks J, Catalfamo J, Zhu Y, Goggs R, Babasyan S J Vet Intern Med. 2024; 38(5):2507-2517.

PMID: 39143652 PMC: 11423463. DOI: 10.1111/jvim.17152.

A prospective evaluation of the prevalence of thromboemboli and associated hemostatic dysfunction in dogs with carcinoma or sarcoma.

Pazzi P, Fosgate G, Rixon A, Hanekom J, Kristensen A, Goddard A J Vet Intern Med. 2023; 37(5):1848-1863.

PMID: 37548637 PMC: 10473004. DOI: 10.1111/jvim.16828.

Interleukin-6 and thrombopoietin concentrations in dogs with carcinoma with and without thrombocytosis.

Cheney A, Woolcock A, Mukhopadhyay A, Knapp D, Moore G J Vet Intern Med. 2021; 36(1):227-233.

PMID: 34881459 PMC: 8783347. DOI: 10.1111/jvim.16317.

References

Gremmel T, Frelinger 3rd A, Michelson A . Platelet Physiology. Semin Thromb Hemost. 2016; 42(3):191-204. DOI: 10.1055/s-0035-1564835. View

Bottsford-Miller J, Choi H, Dalton H, Stone R, Cho M, Haemmerle M . Differential platelet levels affect response to taxane-based therapy in ovarian cancer. Clin Cancer Res. 2014; 21(3):602-10. PMC: 4315757. DOI: 10.1158/1078-0432.CCR-14-0870. View

Neel J, Snyder L, Grindem C . Thrombocytosis: a retrospective study of 165 dogs. Vet Clin Pathol. 2012; 41(2):216-22. DOI: 10.1111/j.1939-165X.2012.00416.x. View

Chadha A, Kocak-Uzel E, Das P, Minsky B, Delclos M, Mahmood U . Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Acta Oncol. 2015; 54(7):971-8. DOI: 10.3109/0284186X.2014.1000466. View

de Sauvage F, Hass P, Spencer S, Malloy B, Gurney A, Spencer S . Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994; 369(6481):533-8. DOI: 10.1038/369533a0. View

Fielder P, Gurney A, Stefanich E, Marian M, Moore M, de Sauvage F . Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood. 1996; 87(6):2154-61. View

Stoffel R, Wiestner A, Skoda R . Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood. 1996; 87(2):567-73. View

Shen X, Xia Y, Lian L, Zhou C, Li X, Han S . Mean platelet volume provides beneficial diagnostic and prognostic information for patients with resectable gastric cancer. Oncol Lett. 2016; 12(4):2501-2506. PMC: 5038875. DOI: 10.3892/ol.2016.4913. View

Yamashita K, Fujinaga T, Miyamoto T, Hagio M, Izumisawa Y, Kotani T . Canine acute phase response: relationship between serum cytokine activity and acute phase protein in dogs. J Vet Med Sci. 1994; 56(3):487-92. DOI: 10.1292/jvms.56.487. View

10.

Leclerc L, Thorin C, Flanagan J, Biourge V, Serisier S, Nguyen P . Higher neonatal growth rate and body condition score at 7 months are predictive factors of obesity in adult female Beagle dogs. BMC Vet Res. 2017; 13(1):104. PMC: 5390368. DOI: 10.1186/s12917-017-0994-7. View

11.

Hollen C, Henthorn J, Koziol J, BURSTEIN S . Serum interleukin-6 levels in patients with thrombocytosis. Leuk Lymphoma. 1992; 8(3):235-41. DOI: 10.3109/10428199209054910. View

12.

Rao A, Rao D . Platelets signal and tumors take off. Blood. 2012; 120(24):4667-8. DOI: 10.1182/blood-2012-09-457325. View

13.

Kilincalp S, Ekiz F, Basar O, Ayte M, Coban S, Yilmaz B . Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets. 2013; 25(8):592-4. DOI: 10.3109/09537104.2013.783689. View

14.

Zhang F, Chen Z, Wang P, Hu X, Gao Y, He J . Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients. Tumour Biol. 2016; 37(7):9323-31. PMC: 4990601. DOI: 10.1007/s13277-015-4774-3. View

15.

Kuter D, Beeler D, Rosenberg R . The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci U S A. 1994; 91(23):11104-8. PMC: 45175. DOI: 10.1073/pnas.91.23.11104. View

16.

Cheney A, Woolcock A, Mukhopadhyay A, Knapp D, Moore G . Interleukin-6 and thrombopoietin concentrations in dogs with carcinoma with and without thrombocytosis. J Vet Intern Med. 2021; 36(1):227-233. PMC: 8783347. DOI: 10.1111/jvim.16317. View

17.

Blay J, Favrot M, Rossi J, Wijdenes J . Role of interleukin-6 in paraneoplastic thrombocytosis. Blood. 1993; 82(7):2261-2. View

18.

Woolcock A, Keenan A, Cheung C, Christian J, Moore G . Thrombocytosis in 715 Dogs (2011-2015). J Vet Intern Med. 2017; 31(6):1691-1699. PMC: 5697177. DOI: 10.1111/jvim.14831. View

19.

Karpatkin S, Pearlstein E . Role of platelets in tumor cell metastases. Ann Intern Med. 1981; 95(5):636-41. DOI: 10.7326/0003-4819-95-5-636. View

20.

Cho M, Bottsford-Miller J, Vasquez H, Stone R, Zand B, Kroll M . Platelets increase the proliferation of ovarian cancer cells. Blood. 2012; 120(24):4869-72. PMC: 3520623. DOI: 10.1182/blood-2012-06-438598. View